Literature DB >> 16544284

Proteotyping of human haptoglobin by MALDI-TOF profiling: Phenotype distribution in a population of toxic oil syndrome patients.

Carlos Rodriguez1, Carmen Quero, Ana Dominguez, Miguel Trigo, Manuel Posada de la Paz, Emilio Gelpi, Joaquin Abian.   

Abstract

Toxic oil syndrome (TOS) is a disease that appeared in Spain in 1981 as a consequence of the ingestion of an aniline-adulterated oil illegally marketed as edible. TOS affected more than 20 000 people and produced over 400 deaths in the first 18 months after the outbreak. There is evidence that genetic factors could play a role in the susceptibility of individuals towards the disease. Recently, we suggested that haptoglobin (Hp) polymorphism could also play a role in TOS. To provide a rapid method for high-throughput Hp phenotyping, we developed a two-step MALDI-TOF procedure that allows specific identification of the three common Hp alpha chains. Resolution of the homologous alpha-1s and alpha-1f chains, which have a mass difference of only 0.043 Da, is obtained after guanidination of the protein with O-methylisourea. We applied this procedure to the study of the distribution of the Hp alleles HP(1s), HP(1f), HP(2) in a control versus a TOS-affected population, both originally exposed to the toxic oil. The MALDI-TOF proteotyping method was validated by a parallel analysis of the serum samples by 2-DE. Data obtained from 54 TOS cases and 48 control individuals indicate significant differences in the distribution of Hp phenotypes in the two populations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16544284     DOI: 10.1002/pmic.200500434

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  1 in total

1.  Identification of single amino acid polymorphisms in MS/MS spectra of peptides.

Authors:  A L Chernobrovkin; V A Mitkevich; I A Popov; M I Indeikina; E V Ilgisonis; A V Lisitsa; A I Archakov
Journal:  Dokl Biochem Biophys       Date:  2011-05-18       Impact factor: 0.788

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.